Carmustine Market Outlook The Carmustine Market is predicted to develop at a compound annual growth rate (CAGR) of 2.84% from 2024 to 2034, when it is projected to reach USD 1.03 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 0.78 Billion in 2024. The colony-stimulating factor medication filgrastim causes the bone marrow to produce more white blood...